Cargando…

Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer’s disease

The relationships between multiple visual rating scales based on structural magnetic resonance imaging (sMRI) with disease severity and cerebrospinal fluid (CSF) biomarkers in patients with Alzheimer’s disease (AD) were ambiguous. In this study, a total of 438 patients with clinically diagnosed AD w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Mei-dan, Liu, Hui, Liu, Xi-xi, Zhang, Wei-wei, Xiao, Xue-wen, Zhang, Si-zhe, Jiang, Ya-ling, Zhou, Hui, Liao, Xin-xin, Zhou, Ya-fang, Tang, Bei-sha, Wang, Jun-Ling, Guo, Ji-feng, Jiao, Bin, Shen, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374170/ https://www.ncbi.nlm.nih.gov/pubmed/35966797 http://dx.doi.org/10.3389/fnagi.2022.906519

Ejemplares similares

Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
por: Sheng, Ze-Hu, et al.
Publicado: (2022)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
por: Lu, Yuanyuan
Publicado: (2022)

Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
por: Mo, Mingshu, et al.
Publicado: (2021)

Application of Artificial Intelligence Modeling Technology Based on Fluid Biopsy to Diagnose Alzheimer’s Disease
por: Sh, Yuan, et al.
Publicado: (2021)

Multiomics Analysis of Structural Magnetic Resonance Imaging of the Brain and Cerebrospinal Fluid Metabolomics in Cognitively Normal and Impaired Adults
por: Eldridge, Ronald C., et al.
Publicado: (2022)

Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis
por: Wang, Ke, et al.
Publicado: (2023)

Rethinking of Alzheimer's disease: Lysosomal overloading and dietary therapy
por: Yuan, Shu, et al.
Publicado: (2023)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022)

The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism
por: Long, Hui-Zhi, et al.
Publicado: (2022)

Postoperative Cognitive Dysfunction and Alzheimer’s Disease: A Transcriptome-Based Comparison of Animal Models
por: Wang, Yi-Wei, et al.
Publicado: (2022)

Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis
por: Du, Ke, et al.
Publicado: (2022)

Association of Circulating Apolipoprotein AI Levels in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Tong, Jun-hui, et al.
Publicado: (2022)

Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive function
por: Zhao, Li-Jing, et al.
Publicado: (2021)

Mendelian randomization analyses of smoking and Alzheimer’s disease in Chinese and Japanese populations
por: Zhu, Yuan, et al.
Publicado: (2023)

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
por: Gui, YaXing, et al.
Publicado: (2015)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021)

X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study
por: Wang, Kai-Wen, et al.
Publicado: (2023)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023)

Constructing a prognostic risk model for Alzheimer’s disease based on ferroptosis
por: Wang, Xiao-Li, et al.
Publicado: (2023)

Recent Advances on Drug Development and Emerging Therapeutic Agents Through Targeting Cellular Homeostasis for Ageing and Cardiovascular Disease
por: Azam, Tayyiba, et al.
Publicado: (2022)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

Corrigendum: Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer's Disease
por: Chen, Chen, et al.
Publicado: (2021)

Alzheimer’s disease and epilepsy: The top 100 cited papers
por: Zhang, Gui-Fen, et al.
Publicado: (2022)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
por: Wang, Hoau-Yan, et al.
Publicado: (2023)

Analysis of Genetic Association Between ABCA7 Polymorphism and Alzheimer’s Disease Risk in the Southern Chinese Population
por: Wang, Lijun, et al.
Publicado: (2022)

Early-stage differentiation between Alzheimer’s disease and frontotemporal lobe degeneration: Clinical, neuropsychology, and neuroimaging features
por: Li, Pan, et al.
Publicado: (2022)

The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases
por: Wang, Hui, et al.
Publicado: (2023)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
por: Lian, Teng-hong, et al.
Publicado: (2020)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
por: Canaslan, Sezgi, et al.
Publicado: (2021)

Platelet Activating Factor Receptor Exaggerates Microglia-Mediated Microenvironment by IL10-STAT3 Signaling: A Novel Potential Biomarker and Target for Diagnosis and Treatment of Alzheimer’s Disease
por: Liu, Junxiu, et al.
Publicado: (2022)

Effectiveness of Physical Activity Interventions on Cognition, Neuropsychiatric Symptoms, and Quality of Life of Alzheimer’s Disease: An Update of a Systematic Review and Meta-Analysis
por: Liang, Ya-Jing, et al.
Publicado: (2022)

Effects of DISC1 on Alzheimer’s disease cell models assessed by iTRAQ proteomics analysis
por: Lu, Jiajie, et al.
Publicado: (2022)

Imaging blood–brain barrier disruption in neuroinflammation and Alzheimer’s disease
por: Lee, Rae-Ling, et al.
Publicado: (2023)

Noninvasive automatic detection of Alzheimer's disease from spontaneous speech: a review
por: Qi, Xiaoke, et al.
Publicado: (2023)

Alzheimer’s disease: an axonal injury disease?
por: Dan, Liang, et al.
Publicado: (2023)

Diagnosis of Alzheimer’s disease via resting-state EEG: integration of spectrum, complexity, and synchronization signal features
por: Zheng, Xiaowei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n51r6pccdq6rv8s9gibqbecesb